Abstract
Cells displaying the classic multidrug resistant (MDR) phenotype possess a transmembrane protein (p170 or P-glycoprotein) which can actively extrude cytotoxic agents from the cytoplasm. A mathematical model of this drug efflux pump has been developed. Outward transport is modeled as a facilitated diffusion process. Since energy-dependent efflux of cytotoxic agents requires that ATP also bind to p170, the model includes a dynamic calculation for efflux rate which considers Michaelis-Menten kinetics for both the substrate agent and ATP. The final system consists of one partial differential equation (PDE) for the facilitated diffusion of substrate agents out of the cell a 2×2 ordinary differential equation (ODE) system for the dynamic calculation of the ATP-ADP pool, and a dynamic algebraic calculation of the efflux rate given substrate levels at the interior cell membrane interface and ATP levels in the cell. A stability analysis of the ATP-ADP pool distribution and a simplistic closed form solution of the linearized PDE are included. Numerical simulations are also provided.
Similar content being viewed by others
Literature
Barman, T. E. 1969.Enzyme Handbook, Vols I and II. Berlin: Springer-Verlag.
Butkovskiiy, A. G. 1982.Green's Functions and Transfer Functions Handbook. Chichester, U. K.: Ellis Harwood.
Coldman A. J. and J. H. Goldie. 1983. A model for the resistance of tumor cells to cancer chemotherapeutic agents.Math. Biosci.,65, 291–307.
Coldman, A. J., J. H. Goldie and V. Ng. 1985. The effects of cellular differentiation on the development of permanent drug resistance.Math. Biosci. 74, 177–198.
Croop, J. M., P. Gros and D. E. Housman. 1988. Genetics of multidrug resistance.J. clin. Invest. 81, 1303–1309.
Curt, G. A., N. J. Clendeninn and B. A. Chabner. 1984. Drug resistance in cancer.Cancer Treat. Rep. 68, 87–99.
Day, R. S. 1986a. A branching process model for heterogeneous cell populations.Math. Biosci. 78, 73–90.
Day, R. S. 1986b. Treatment sequencing, asymmetry, and uncertainty: protocol strategies for combination chemotherapy.Caner Res. 46, 3876–3885.
Goldie, J. H. and A. J. Coldman. 1979. A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate.Cancer Treat. Rep. 63, 1727–1733.
Goldie, J. H. and A. J. Coldman. 1984. The genetic origin of drug resistance in neoplasms: implications for systemic therapy.Cancer Treat. Rep. 67, 923–931.
Goldie, J. H., A. J. Coldman and G. A. Gudauskas. 1982. Rationale for the use of alternating non-cross-resistant chemotherapy.Cancer Treat. Rep. 66, 439–449.
Gottesman, M. and I. Pastan. 1988. Resistance to multiple chemotherapeutic agents in human cancer cells.Tr. Pharmacol. Sci. 9, 54–58.
Hamada, H. and T. Tsuruo. 1988. Characterization of the ATPase activity of the Mr 170,000 to 180,000 membrane glycoprotein (P-glycoprotein) associated with multidrug resistance in K562/ADM Cells.Cancer Res. 48, 4926–4932.
Harris, A. L., 1984. Drug resistance to cancer chemotherapyDrugs of Today 20, 657–663.
Horio, M., I. Pastan, M. Gottesman and J. Handler. 1990. Transpithelial transport of vinblastine by kidney-derived cell lines. Application of a new kinetic model to estimatein situ K m of the pump.Biochim. Biophys. Acta 1027, 116–122.
Inaba, M., H. Kobayashi, Y. Sakurai and R. K. Johnson. 1979. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.Cancer Res.,42, 4730–4733.
Joshi, R. R. 1985. On control of the function of the sodium-potassium pump in malignant cells.Bull. math. Biol. 47, 551–564.
Juliano, R. L. and C. Ling. 1976. Cell surface P-glycoprotein modulating drug permeability in chinese hamster ovary cell mutants.Biochim. Biophys. Acta 455, 152–162.
Kartner, N., J. R. Riordan and V. Ling. 1983. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines.Science 221, 1285–1288.
Ling, V. and L. H. Thompson. 1974. Reduced permeability in CHO cells as a mechanism of resistance to colchicine.J. Cell Physiol. 83, 103–116.
Marx, J. L. 1986. Drug resistance of cancer cells probed.Science 234, 818–820.
Michelson, S. and D. Slate. 1989. Emergence of the drug-resistant phenotype in tumor subpopulations: a hybrid model.JNCI 81, 1392–1401.
Moscow, J. A. and K. H. Cowan. 1988. Multidrug resistance.JNCI 80, 14–20.
Naito, M., H. Hamada and T. Tsuruo. 1988. ATP/Mg2+-dependent binding of vincristine to the plasma membrane of multidrug-resistant K562 cells.J. biol. Chem. 263, 11887–11891.
Pastan, I. and M. Gottesman. 1987. Multiple drug resistance in human cancer.New Engl. J. Med. 316, 1388–1393.
Schimke, R. T. 1984. Gene amplification, Drug resistance, and cancer.Cancer Res. 44, 1735–1742.
Slate, D. L. and S. Michelson. 1992. Drug resistance reversal strategies: a comparison of experimental data with model predictions.JNCI, in press.
Stein, W. D. 1986.Transport and Diffusion Across Cell Membranes. San Diego, CA: Academic Press.
Toko, K., M. Nosaka, T. Fujiyoshi, K. Yamafuji and K. Ogata. 1988. Periodic band patterns as a dissipative structure in ion transport systems with cylindrical shape.Bull. math. Biol. 50, 255–288.
Tsuruo, T., H. Iida, S. Tsukagoshi and Y. Sakurai. 1982. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.Cancer Res. 42, 4730–4733.
Warr, J. R. and G. F. Atkinson. 1988. Genetic aspects of resistance to anticancer drugs.Physiol. Rev. 66, 1–26.
Watanabe, T., M. Inaba and Y. Sugiyama. 1989. Saturable process involved in active efflux of vincristine as a mechanism of multidrug resistance in P388 leukemia cells.Pharm. Res. 6, 690–696.
Willingham, M. C., M. M. Cornwell, C. O. Cardarelli, M. M. Gottesman and I. Pastan. 1986. Single cell analysis of daunomycin uptake in multidrug resistant and sensitive KB cells: effects of verapamil and other drugs.Cancer Res. 46, 5941–5946.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Michelson, S., Slate, D. A mathematical model of the P-glycoprotein pump as a mediator of multidrug resistance. Bltn Mathcal Biology 54, 1023–1038 (1992). https://doi.org/10.1007/BF02460664
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02460664